US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Rapport Therapeutics, Inc.

32.17

-0.6600-2.01%

Post-market: 31.74-0.4300-1.34%19:59 EDT

Volume:277.63K

Turnover:8.94M

Market Cap:1.54B

PE:-10.54

High:34.48

Open:33.33

Low:31.77

Close:32.83

52wk High:52.93

52wk Low:23.75

Shares:47.98M

Float Shares:30.39M

Volume Ratio:0.50

T/O Rate:0.91%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.0525

EPS(LYR):-2.8633

ROE:-39.96%

ROA:-25.78%

PB:3.65

PE(LYR):-11.24

Loading ...

Overview Company News Filings

Rapport Therapeutics COO Cheryl Gault Sells USD 332,992 of Common Stock

Rapport Therapeutics CEO Abraham Ceesay Disposes of USD 87,135.01 in Common Shares

Rapport drops after CEO presents at TD Cowen Neuropsychiatry Summit

Rapport Therapeutics Down over 16%, on Pace for Largest Percent Decrease in over a Year

Analysts Offer Insights on NA Companies: Andersen Group, Inc. Class A (ANDG) and Rapport Therapeutics, Inc. (RAPP)

Rapport Therapeutics, Inc. (RAPP) Receives a Buy from TD Cowen

Rapport Therapeutics price target raised to $75 from $65 at BTIG

Rapport Therapeutics, Inc. : Btig Raises Target Price to $75 from $65

THOMSON REUTERS

U.S. Research Roundup-Domino's, McDonald's, Starbucks

Rapport Therapeutics CEO Abraham Ceesay Sells $373,980 of Common Shares

Analysts Conflicted on These NA Names: Fiserv (FISV) and Rapport Therapeutics, Inc. (RAPP)

Rapport Therapeutics to Join Cantor Global Healthcare Conference Fireside Chat

Rapport Therapeutics to Participate in Upcoming Investor Conferences

Rapport Therapeutics Chief Development Officer Krishnaswamy Yeleswaram Disposes of Common Shares Worth $2.51 Million

Rapport Therapeutics to Host Virtual KOL Event on Bipolar Mania and RAP-219 Program

Rapport Therapeutics Chief Development Officer Krishnaswamy Yeleswaram Disposes of 404 Common Shares Worth $20,159.6

Analysts Have Conflicting Sentiments on These NA Companies: ServiceTitan, Inc. Class A (TTAN), Rapport Therapeutics, Inc. (RAPP) and Amentum Holdings, Inc. (AMTM)

Analysts Offer Insights on NA Companies: Rapport Therapeutics, Inc. (RAPP) and SpaceX (SPCX)

Does Widening Losses And Higher EPS Drag Change The Bull Case For Rapport Therapeutics (RAPP)?

Simply Wall St.

Rapport Therapeutics Price Target Maintained with a $65.00/Share by BTIG

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigeractivity.com/stock/RAPP/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"RAPP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RAPP\",,,,,undefined,":{"symbol":"RAPP","market":"US","secType":"STK","nameCN":"Rapport Therapeutics, Inc.","latestPrice":32.17,"timestamp":1790971200000,"preClose":32.83,"halted":0,"volume":277626,"hourTrading":{"tag":"盘后","latestPrice":31.74,"preClose":32.17,"latestTime":"19:59 EDT","volume":8065,"amount":259147.3,"timestamp":1790985592488,"change":-0.43,"changeRate":-0.013366,"amplitude":0.017408},"delay":0,"changeRate":-0.020103563813585034,"floatShares":30393800,"shares":47978286,"eps":-3.052456,"marketStatus":"Market Closed","change":-0.66,"latestTime":"10-02 16:00:00 EDT","open":33.33,"high":34.48,"low":31.77,"amount":8944912.050288,"amplitude":0.082546,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.052456,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"listingDate":1717732800000,"exchange":"NASDAQ","adjPreClose":32.83,"preHourTrading":{"tag":"盘前","latestPrice":33.37,"preClose":32.83,"latestTime":"04:01 EDT","volume":6,"amount":196.64570400000002,"timestamp":1790928062864,"change":0.54,"changeRate":0.016448,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":31.74,"preClose":32.17,"latestTime":"19:59 EDT","volume":8065,"amount":259147.3,"timestamp":1790985592488,"change":-0.43,"changeRate":-0.013366,"amplitude":0.017408},"volumeRatio":0.49592578678816457,"impliedVol":1.4481,"impliedVolPercentile":0.9482},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RAPP\",,,,,undefined,":{"symbol":"RAPP","floatShares":30393800,"roa":"-25.78%","roe":"-39.96%","lyrEps":-2.863342,"volumeRatio":0.49592578678816457,"shares":47978286,"dividePrice":0,"high":34.48,"amplitude":0.082546,"preClose":32.83,"low":31.77,"week52Low":23.75,"pbRate":"3.65","psRate":"77.17","week52High":52.93,"institutionHeld":0,"latestPrice":32.17,"eps":-3.052456,"divideRate":0,"volume":277626,"delay":0,"ttmEps":-3.052456,"open":33.33,"prevYearClose":30.34,"prevWeekClose":33.91,"prevMonthClose":33.6,"prevQuarterClose":33.6,"fiveDayClose":33.91,"twentyDayClose":47.65,"sixtyDayClose":42.05},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RAPP\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-05","symbol":"RAPP","fiscalQuarterEnding":"2026/06","expectedEps":-0.93,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1785902400000,"reportTimeType":"pre","actualEps":-1.19},{"market":"US","date":"2026-05-07","symbol":"RAPP","fiscalQuarterEnding":"2026/03","expectedEps":-0.56,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"pre","actualEps":-0.42},{"market":"US","date":"2026-03-10","symbol":"RAPP","fiscalQuarterEnding":"2025/12","expectedEps":-0.65,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1773115200000,"reportTimeType":"pre","actualEps":-0.72},{"market":"US","date":"2025-11-06","symbol":"RAPP","fiscalQuarterEnding":"2025/09","expectedEps":-0.77,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"pre","actualEps":-0.71},{"market":"US","date":"2025-08-07","symbol":"RAPP","fiscalQuarterEnding":"2025/06","expectedEps":-0.87,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"pre","actualEps":-0.75}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RAPP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RAPP\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4615,"buy":0.5385,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5385,"analysts":13,"updateTime":1785211200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/RAPP\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"RAPP","date":"2026-10-02","current":-10.539054,"percent":0.627148,"low":-19.654107,"twenty":-15.71898,"median":-12.913036,"eighty":-6.468149,"high":-3.640031,"avg":-11.823269,"sd":4.348231,"marketCap":1575127129},"quantilePoints":[{"date":"2024-06-07","current":-14.341434,"twenty":-13.293406,"median":-11.721364,"eighty":-11.721364,"marketCap":735830305},{"date":"2024-06-14","current":-17.322989,"twenty":-16.966549,"median":-15.024031,"eighty":-12.769392,"marketCap":888807905},{"date":"2024-06-21","current":-15.733266,"twenty":-17.881887,"median":-15.772475,"eighty":-14.348329,"marketCap":807242405},{"date":"2024-06-28","current":-16.581593,"twenty":-17.17471,"median":-16.18238,"eighty":-14.635158,"marketCap":850768389},{"date":"2024-07-05","current":-17.059223,"twenty":-17.829134,"median":-16.431888,"eighty":-15.672154,"marketCap":875274616},{"date":"2024-07-12","current":-18.299635,"twenty":-18.057796,"median":-16.595851,"eighty":-15.733266,"marketCap":938917651},{"date":"2024-07-19","current":-14.343149,"twenty":-18.092899,"median":-16.610109,"eighty":-15.733266,"marketCap":735918314},{"date":"2024-07-26","current":-16.431888,"twenty":-18.057796,"median":-16.50674,"eighty":-14.592658,"marketCap":843087333},{"date":"2024-08-02","current":-15.740395,"twenty":-18.021611,"median":-16.417631,"eighty":-14.614044,"marketCap":807608170},{"date":"2024-08-09","current":-11.062669,"twenty":-17.829134,"median":-16.189509,"eighty":-14.507112,"marketCap":697147270},{"date":"2024-08-16","current":-12.078391,"twenty":-17.822005,"median":-15.897228,"eighty":-14.341434,"marketCap":761156070},{"date":"2024-08-23","current":-12.943207,"twenty":-17.322989,"median":-15.776039,"eighty":-12.769083,"marketCap":815654991},{"date":"2024-08-30","current":-12.623979,"twenty":-17.301602,"median":-15.672154,"eighty":-12.252515,"marketCap":795537939},{"date":"2024-09-06","current":-11.799793,"twenty":-17.107699,"median":-14.956226,"eighty":-12.030797,"marketCap":743599370},{"date":"2024-09-13","current":-11.027844,"twenty":-17.007896,"median":-14.603351,"eighty":-11.813723,"marketCap":694952683},{"date":"2024-09-20","current":-12.322165,"twenty":-16.6871,"median":-14.421566,"eighty":-11.752199,"marketCap":776518182},{"date":"2024-09-27","current":-12.380206,"twenty":-16.587296,"median":-14.342291,"eighty":-11.752199,"marketCap":780175827},{"date":"2024-10-04","current":-12.072587,"twenty":-16.581593,"median":-13.041877,"eighty":-11.742318,"marketCap":760790305},{"date":"2024-10-11","current":-12.798103,"twenty":-16.461829,"median":-12.783593,"eighty":-11.721364,"marketCap":806510876},{"date":"2024-10-18","current":-15.061713,"twenty":-16.461829,"median":-13.041877,"eighty":-11.742318,"marketCap":949159059},{"date":"2024-10-25","current":-14.057599,"twenty":-16.431888,"median":-14.106934,"eighty":-11.752199,"marketCap":885881788},{"date":"2024-11-01","current":-14.289764,"twenty":-16.420482,"median":-14.289764,"eighty":-11.78122,"marketCap":900512371},{"date":"2024-11-08","current":-13.587752,"twenty":-16.360601,"median":-14.196898,"eighty":-11.792828,"marketCap":976225637},{"date":"2024-11-15","current":-10.665545,"twenty":-16.293733,"median":-13.709352,"eighty":-11.752199,"marketCap":766276774},{"date":"2024-11-22","current":-11.755009,"twenty":-16.213426,"median":-13.641207,"eighty":-11.719637,"marketCap":844550392},{"date":"2024-11-29","current":-11.627735,"twenty":-16.188083,"median":-13.405914,"eighty":-11.573511,"marketCap":835406277},{"date":"2024-12-06","current":-10.416089,"twenty":-16.139607,"median":-12.943207,"eighty":-11.450385,"marketCap":748354310},{"date":"2024-12-13","current":-9.555718,"twenty":-15.982774,"median":-12.73716,"eighty":-11.371152,"marketCap":686540097},{"date":"2024-12-20","current":-9.199351,"twenty":-15.858733,"median":-12.415031,"eighty":-11.254059,"marketCap":660936577},{"date":"2024-12-27","current":-9.688083,"twenty":-15.824515,"median":-12.350651,"eighty":-11.045256,"marketCap":696049976},{"date":"2025-01-03","current":-9.917175,"twenty":-15.797425,"median":-12.316361,"eighty":-10.975704,"marketCap":712509382},{"date":"2025-01-10","current":-7.539701,"twenty":-15.740395,"median":-12.304752,"eighty":-10.859002,"marketCap":541697328},{"date":"2025-01-17","current":-6.460419,"twenty":-15.733266,"median":-12.215086,"eighty":-10.644772,"marketCap":464155239},{"date":"2025-01-24","current":-7.076424,"twenty":-15.684376,"median":-12.087097,"eighty":-10.43238,"marketCap":508412752},{"date":"2025-01-31","current":-8.354253,"twenty":-15.597056,"median":-11.915876,"eighty":-10.137105,"marketCap":600219659},{"date":"2025-02-07","current":-8.211706,"twenty":-15.257893,"median":-11.843324,"eighty":-9.686047,"marketCap":589978251},{"date":"2025-02-14","current":-8.094614,"twenty":-15.103195,"median":-11.828814,"eighty":-9.441681,"marketCap":581565666},{"date":"2025-02-21","current":-6.455328,"twenty":-15.070846,"median":-11.799793,"eighty":-9.297098,"marketCap":463789474},{"date":"2025-02-28","current":-5.106225,"twenty":-15.037336,"median":-11.771597,"eighty":-9.077168,"marketCap":366861863},{"date":"2025-03-07","current":-4.373128,"twenty":-15.01412,"median":-11.747556,"eighty":-8.771711,"marketCap":314191765},{"date":"2025-03-14","current":-4.898381,"twenty":-14.977526,"median":-11.717047,"eighty":-8.416363,"marketCap":383577552},{"date":"2025-03-21","current":-4.530187,"twenty":-14.817535,"median":-11.627735,"eighty":-8.164869,"marketCap":354745367},{"date":"2025-03-28","current":-4.68399,"twenty":-14.676319,"median":-11.461087,"eighty":-7.790176,"marketCap":366789191},{"date":"2025-04-04","current":-4.189957,"twenty":-14.640334,"median":-11.410917,"eighty":-7.133443,"marketCap":328102968},{"date":"2025-04-11","current":-4.315796,"twenty":-14.632186,"median":-11.370643,"eighty":-6.989878,"marketCap":337957006},{"date":"2025-04-17","current":-4.730597,"twenty":-14.622599,"median":-11.327444,"eighty":-6.74653,"marketCap":370438835},{"date":"2025-04-25","current":-4.949801,"twenty":-14.60549,"median":-11.189913,"eighty":-6.457364,"marketCap":387604034},{"date":"2025-05-02","current":-5.280719,"twenty":-14.55844,"median":-11.048158,"eighty":-5.528775,"marketCap":413517298},{"date":"2025-05-09","current":-4.693792,"twenty":-14.472894,"median":-10.976093,"eighty":-5.332796,"marketCap":374099938},{"date":"2025-05-16","current":-4.560992,"twenty":-14.4176,"median":-10.940782,"eighty":-5.2164,"marketCap":363515647},{"date":"2025-05-23","current":-5.092192,"twenty":-14.397354,"median":-10.8247,"eighty":-5.097805,"marketCap":405852811},{"date":"2025-05-30","current":-3.896992,"twenty":-14.370288,"median":-10.665545,"eighty":-4.981023,"marketCap":310594193},{"date":"2025-06-06","current":-5.646289,"twenty":-14.346875,"median":-10.527934,"eighty":-4.950803,"marketCap":450014853},{"date":"2025-06-13","current":-5.101351,"twenty":-14.342806,"median":-10.416089,"eighty":-4.981023,"marketCap":406582762},{"date":"2025-06-20","current":-5.050978,"twenty":-14.341434,"median":-10.309179,"eighty":-5.014344,"marketCap":402568031},{"date":"2025-06-27","current":-5.408165,"twenty":-14.289764,"median":-9.866266,"eighty":-5.000606,"marketCap":431036124},{"date":"2025-07-03","current":-5.513507,"twenty":-14.247974,"median":-9.698265,"eighty":-5.011596,"marketCap":439432031},{"date":"2025-07-11","current":-7.043002,"twenty":-14.172521,"median":-9.586263,"eighty":-5.043651,"marketCap":561334272},{"date":"2025-07-18","current":-6.795718,"twenty":-14.077333,"median":-9.430989,"eighty":-5.078884,"marketCap":541625526},{"date":"2025-07-25","current":-7.610838,"twenty":-13.779001,"median":-9.362262,"eighty":-5.090926,"marketCap":606591391},{"date":"2025-08-01","current":-6.57591,"twenty":-13.6976,"median":-9.168805,"eighty":-5.092192,"marketCap":524106641},{"date":"2025-08-08","current":-6.368661,"twenty":-13.694662,"median":-9.054259,"eighty":-5.099519,"marketCap":562429202},{"date":"2025-08-15","current":-6.17446,"twenty":-13.609134,"median":-8.982986,"eighty":-5.10525,"marketCap":545278924},{"date":"2025-08-22","current":-6.170327,"twenty":-13.473486,"median":-8.4968,"eighty":-5.115317,"marketCap":544913945},{"date":"2025-08-29","current":-6.943168,"twenty":-13.38251,"median":-8.407708,"eighty":-5.122916,"marketCap":613165056},{"date":"2025-09-05","current":-6.343907,"twenty":-13.171889,"median":-8.282979,"eighty":-5.126995,"marketCap":560243072},{"date":"2025-09-12","current":-9.588184,"twenty":-13.020376,"median":-8.364435,"eighty":-5.143059,"marketCap":846751744},{"date":"2025-09-19","current":-14.281097,"twenty":-13.398113,"median":-8.486618,"eighty":-5.165131,"marketCap":1261192245},{"date":"2025-09-26","current":-13.038354,"twenty":-13.650327,"median":-8.934622,"eighty":-5.176938,"marketCap":1151443158},{"date":"2025-10-03","current":-14.902468,"twenty":-13.718742,"median":-9.051713,"eighty":-5.195691,"marketCap":1316066789},{"date":"2025-10-10","current":-13.962579,"twenty":-13.896787,"median":-9.158623,"eighty":-5.223161,"marketCap":1233063277},{"date":"2025-10-17","current":-12.986138,"twenty":-13.856058,"median":-9.228454,"eighty":-5.262092,"marketCap":1146831851},{"date":"2025-10-24","current":-13.675391,"twenty":-13.856058,"median":-9.397898,"eighty":-5.294604,"marketCap":1207701093},{"date":"2025-10-31","current":-14.035682,"twenty":-13.934383,"median":-9.502263,"eighty":-5.303959,"marketCap":1239519106},{"date":"2025-11-07","current":-11.969573,"twenty":-13.970933,"median":-9.588184,"eighty":-5.319746,"marketCap":1169427252},{"date":"2025-11-14","current":-12.034803,"twenty":-13.934383,"median":-9.698265,"eighty":-5.33408,"marketCap":1175800274},{"date":"2025-11-21","current":-13.098276,"twenty":-13.915585,"median":-9.917175,"eighty":-5.342242,"marketCap":1279701555},{"date":"2025-11-28","current":-14.493474,"twenty":-13.931568,"median":-10.309179,"eighty":-5.356195,"marketCap":1416012409},{"date":"2025-12-05","current":-14.000764,"twenty":-13.954437,"median":-10.426271,"eighty":-5.376155,"marketCap":1367874660},{"date":"2025-12-12","current":-14.039791,"twenty":-13.99491,"median":-10.604143,"eighty":-5.393122,"marketCap":1371687551},{"date":"2025-12-19","current":-14.459326,"twenty":-14.050476,"median":-10.719003,"eighty":-5.431972,"marketCap":1412676130},{"date":"2025-12-26","current":-15.088628,"twenty":-14.119227,"median":-10.841851,"eighty":-5.476848,"marketCap":1474158998},{"date":"2026-01-02","current":-14.800808,"twenty":-14.281097,"median":-10.940782,"eighty":-5.513507,"marketCap":1446038926},{"date":"2026-01-09","current":-13.81051,"twenty":-14.281097,"median":-10.976093,"eighty":-5.513507,"marketCap":1349286816},{"date":"2026-01-16","current":-13.103154,"twenty":-14.237527,"median":-11.048158,"eighty":-5.513507,"marketCap":1280178166},{"date":"2026-01-23","current":-13.620256,"twenty":-14.172521,"median":-11.156822,"eighty":-5.535473,"marketCap":1330698972},{"date":"2026-01-30","current":-13.049493,"twenty":-14.13499,"median":-11.312246,"eighty":-5.592253,"marketCap":1274935441},{"date":"2026-02-06","current":-12.464095,"twenty":-14.128014,"median":-11.370643,"eighty":-5.617345,"marketCap":1217742075},{"date":"2026-02-13","current":-13.644647,"twenty":-14.087483,"median":-11.410917,"eighty":-5.641114,"marketCap":1333082029},{"date":"2026-02-20","current":-14.630067,"twenty":-14.14031,"median":-11.45735,"eighty":-5.660027,"marketCap":1429357528},{"date":"2026-02-27","current":-14.391029,"twenty":-14.240388,"median":-11.53826,"eighty":-5.735139,"marketCap":1406003571},{"date":"2026-03-06","current":-14.464204,"twenty":-14.259247,"median":-11.689515,"eighty":-5.790087,"marketCap":1413152741},{"date":"2026-03-13","current":-12.292686,"twenty":-14.284564,"median":-11.721364,"eighty":-5.811144,"marketCap":1370425569},{"date":"2026-03-20","current":-11.773881,"twenty":-14.259247,"median":-11.747556,"eighty":-5.859217,"marketCap":1312587588},{"date":"2026-03-27","current":-12.434179,"twenty":-14.240388,"median":-11.754185,"eighty":-5.89508,"marketCap":1386199565},{"date":"2026-04-02","current":-13.578981,"twenty":-14.21307,"median":-11.781033,"eighty":-5.908305,"marketCap":1513825524},{"date":"2026-04-10","current":-14.672331,"twenty":-14.286297,"median":-11.799793,"eighty":-5.924837,"marketCap":1635715486},{"date":"2026-04-17","current":-16.95336,"twenty":-14.342463,"median":-11.834618,"eighty":-5.953085,"marketCap":1890011406},{"date":"2026-04-24","current":-15.589888,"twenty":-14.384981,"median":-11.842483,"eighty":-5.987204,"marketCap":1738007454},{"date":"2026-05-01","current":-14.207247,"twenty":-14.395165,"median":-11.879676,"eighty":-6.003597,"marketCap":1583866549},{"date":"2026-05-08","current":-17.794666,"twenty":-14.442977,"median":-11.889648,"eighty":-6.018516,"marketCap":1908958386},{"date":"2026-05-15","current":-16.919116,"twenty":-14.478378,"median":-11.936812,"eighty":-6.027747,"marketCap":1815031955},{"date":"2026-05-22","current":-16.361832,"twenty":-14.513564,"median":-11.969573,"eighty":-6.033101,"marketCap":1755248294},{"date":"2026-05-29","current":-17.605688,"twenty":-14.602401,"median":-12.072587,"eighty":-6.039697,"marketCap":1888685426},{"date":"2026-06-05","current":-16.714035,"twenty":-14.636423,"median":-12.104204,"eighty":-6.052541,"marketCap":1793031568},{"date":"2026-06-12","current":-15.697551,"twenty":-14.689254,"median":-12.211886,"eighty":-6.082711,"marketCap":1683986170},{"date":"2026-06-18","current":-16.437623,"twenty":-14.725074,"median":-12.249449,"eighty":-6.104202,"marketCap":1763378872},{"date":"2026-06-26","current":-17.347109,"twenty":-14.756903,"median":-12.285702,"eighty":-6.170327,"marketCap":1860945807},{"date":"2026-07-02","current":-17.561106,"twenty":-14.865035,"median":-12.307654,"eighty":-6.173633,"marketCap":1883902733},{"date":"2026-07-10","current":-18.747004,"twenty":-14.94702,"median":-12.322165,"eighty":-6.184379,"marketCap":2011122364},{"date":"2026-07-17","current":-17.891017,"twenty":-15.011798,"median":-12.351888,"eighty":-6.210003,"marketCap":1919294660},{"date":"2026-07-24","current":-18.4483,"twenty":-15.085362,"median":-12.382727,"eighty":-6.318283,"marketCap":1979078322},{"date":"2026-07-31","current":-19.072457,"twenty":-15.112377,"median":-12.415031,"eighty":-6.358759,"marketCap":2046036022},{"date":"2026-08-07","current":-16.213135,"twenty":-15.201543,"median":-12.451899,"eighty":-6.368734,"marketCap":2223793556},{"date":"2026-08-14","current":-16.566431,"twenty":-15.503178,"median":-12.623979,"eighty":-6.396893,"marketCap":2272251624},{"date":"2026-08-21","current":-16.737832,"twenty":-15.582924,"median":-12.704769,"eighty":-6.419712,"marketCap":2295760985},{"date":"2026-08-28","current":-17.780229,"twenty":-15.689526,"median":-12.798103,"eighty":-6.426595,"marketCap":2438736277},{"date":"2026-09-04","current":-16.667872,"twenty":-15.740131,"median":-12.897046,"eighty":-6.440085,"marketCap":2286165327},{"date":"2026-09-11","current":-15.202219,"twenty":-15.758139,"median":-12.908089,"eighty":-6.450467,"marketCap":2085136309},{"date":"2026-09-18","current":-14.674024,"twenty":-15.740219,"median":-12.981196,"eighty":-6.457364,"marketCap":2012689097},{"date":"2026-09-25","current":-11.833664,"twenty":-15.737279,"median":-12.983667,"eighty":-6.460419,"marketCap":1623105415},{"date":"2026-10-02","current":-11.483866,"twenty":-15.71898,"median":-12.913036,"eighty":-6.468149,"marketCap":1575127129}],"updateTime":1791051708744},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RAPP\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2672762376","title":"Rapport Therapeutics COO Cheryl Gault Sells USD 332,992 of Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2672762376","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672762376?lang=en_us&edition=fundamental","pubTime":"2026-10-02 04:31","pubTimestamp":1790886672,"startTime":"0","endTime":"0","summary":"Rapport Therapeutics COO Cheryl Gault sells USD 332,992 of common stockRapport Therapeutics COO Cheryl Gault sold 10,000 common shares on Sept. 30, 2026.Sales priced at USD 33.0364 per share for 7,925","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nNDL43s8Dd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Rapport Therapeutics COO Cheryl Gault Sells USD 332,992 of Common Stock","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","RAPP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670441886","title":"Rapport Therapeutics CEO Abraham Ceesay Disposes of USD 87,135.01 in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2670441886","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670441886?lang=en_us&edition=fundamental","pubTime":"2026-09-25 04:05","pubTimestamp":1790280352,"startTime":"0","endTime":"0","summary":"Rapport Therapeutics CEO Abraham Ceesay disposes of USD 87,135.01 in common sharesRapport Therapeutics CEO Abraham Ceesay sold 2,210 common shares on Sept. 23, 2026.Sales priced at USD 39.0523, USD 39","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nNDL2x29SH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Rapport Therapeutics CEO Abraham Ceesay Disposes of USD 87,135.01 in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","RAPP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669435932","title":"Rapport drops after CEO presents at TD Cowen Neuropsychiatry Summit","url":"https://stock-news.laohu8.com/highlight/detail?id=2669435932","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669435932?lang=en_us&edition=fundamental","pubTime":"2026-09-24 03:00","pubTimestamp":1790190017,"startTime":"0","endTime":"0","summary":"Shares of Rapport Therapeutics (RAPP) were dropping after the company presented at TD Cowen’s 6th Annual Novel Mechanisms in Neuropsychiatry Summit...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/rapport-drops-after-ceo-presents-at-td-cowen-neuropsychiatry-summit-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/rapport-drops-after-ceo-presents-at-td-cowen-neuropsychiatry-summit-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4127","RAPP","COWN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669333334","title":"Rapport Therapeutics Down over 16%, on Pace for Largest Percent Decrease in over a Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2669333334","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669333334?lang=en_us&edition=fundamental","pubTime":"2026-09-24 02:01","pubTimestamp":1790186460,"startTime":"0","endTime":"0","summary":"Rapport Therapeutics, Inc.  is currently at $34.56, down $6.91 or 16.66%--Would be lowest close since May 19, 2026, when it closed at $34.37--On pace for largest percent decrease since Sept. 10, 2025, when it fell 20.09%--Currently down three of the past four days--Down 28.99% month-to-date; on pace for worst month since Feb. 2025, when it fell 38.88%--Up 13.91% year-to-date--Down 34.17% from its all-time closing high of $52.50 on Aug. 26, 2026--Up 28.19% from 52 weeks ago , when it closed at $26.96--Down 34.17% from its 52-week closing high of $52.50 on Aug. 26, 2026--Up 41.81% from its 52-week closing low of $24.37 on Nov. 14, 2025--Traded as low as $34.40; lowest intraday level since June 11, 2026, when it hit $33.51--Down 17.06% at today's intraday low; largest intraday percent decrease since Sept. 10, 2025, when it fell as much as 20.23%All data as of 1:58:13 PM ETSource: Dow Jones Market Data, FactSet","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"Rapport Therapeutics Down over 16%, on Pace for Largest Percent Decrease in over a Year","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","RAPP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669855174","title":"Analysts Offer Insights on NA Companies: Andersen Group, Inc. Class A (ANDG) and Rapport Therapeutics, Inc. (RAPP)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669855174","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669855174?lang=en_us&edition=fundamental","pubTime":"2026-09-23 20:10","pubTimestamp":1790165415,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the NA sector as 2 analysts just weighed in on Andersen Group, Inc. Class A (ANDG) and Rapport Therapeutics...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-andersen-group-inc-class-a-andg-and-rapport-therapeutics-inc-rapp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-andersen-group-inc-class-a-andg-and-rapport-therapeutics-inc-rapp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RAPP","BK4007","NA","ANDG","BK4141","BK4123"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669106038","title":"Rapport Therapeutics, Inc. (RAPP) Receives a Buy from TD Cowen","url":"https://stock-news.laohu8.com/highlight/detail?id=2669106038","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669106038?lang=en_us&edition=fundamental","pubTime":"2026-09-23 16:05","pubTimestamp":1790150734,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Joseph Thome from TD Cowen maintained a Buy rating on Rapport Therapeutics, Inc.. The company’s shares closed yeste...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/rapport-therapeutics-inc-rapp-receives-a-buy-from-td-cowen-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/rapport-therapeutics-inc-rapp-receives-a-buy-from-td-cowen-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4127","RAPP","COWN","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667600914","title":"Rapport Therapeutics price target raised to $75 from $65 at BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2667600914","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667600914?lang=en_us&edition=fundamental","pubTime":"2026-09-16 19:10","pubTimestamp":1789557042,"startTime":"0","endTime":"0","summary":"BTIG analyst Kambiz Yazdi raised the firm’s price target on Rapport Therapeutics (RAPP) to $75 from $65 and keeps a Buy rating on the shares. The f...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/rapport-therapeutics-price-target-raised-to-75-from-65-at-btig-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/rapport-therapeutics-price-target-raised-to-75-from-65-at-btig-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RAPP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667260248","title":"Rapport Therapeutics, Inc. : Btig Raises Target Price to $75 from $65","url":"https://stock-news.laohu8.com/highlight/detail?id=2667260248","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667260248?lang=en_us&edition=fundamental","pubTime":"2026-09-16 18:27","pubTimestamp":1789554470,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nFWN4570QV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","RAPP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667608922","title":"U.S. Research Roundup-Domino's, McDonald's, Starbucks","url":"https://stock-news.laohu8.com/highlight/detail?id=2667608922","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667608922?lang=en_us&edition=fundamental","pubTime":"2026-09-16 15:02","pubTimestamp":1789542132,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Domino's, McDonald's, StarbucksSept 16 (Reuters)-Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Domino's, McD","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nL4N4580E9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAVA","DTM","FTAG","ABTC","FCEL","CCL","AVAV","DHI","ABNG","SBUX","KBH","BKV","SLDB","EMET","BKNG","FCX","GOLF","NEM","RGLD","IRON","COPP","AWAY","CRM","IMMX","SGDM","FTAI","BROS","MDST","ABNB","RAPP","PYZ","SHAK","MTH","RCUS","XAR","JBHT","QSR","CMCSA","RYAN","MCD","LEN","CBZ","CTVA","DPZ","CMGG","DRI","PHM","CMG","EXPE","AJG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666253723","title":"Rapport Therapeutics CEO Abraham Ceesay Sells $373,980 of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2666253723","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666253723?lang=en_us&edition=fundamental","pubTime":"2026-09-10 04:06","pubTimestamp":1788984374,"startTime":"0","endTime":"0","summary":"Rapport Therapeutics CEO Abraham Ceesay sells $373,980 of common sharesRapport Therapeutics CEO and director Abraham Ceesay sold 8,210 common shares on Sep. 8, 2026.Sales priced at USD 45.56 and USD 4","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nNDL6DYrRD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Rapport Therapeutics CEO Abraham Ceesay Sells $373,980 of Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","RAPP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664812015","title":"Analysts Conflicted on These NA Names: Fiserv (FISV) and Rapport Therapeutics, Inc. (RAPP)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664812015","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664812015?lang=en_us&edition=fundamental","pubTime":"2026-09-02 21:40","pubTimestamp":1788356410,"startTime":"0","endTime":"0","summary":"Companies in the NA sector have received a lot of coverage today as analysts weigh in on Fiserv (FISV) and Rapport Therapeutics, Inc. (RAPP). Fiser...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-na-names-fiserv-fisv-and-rapport-therapeutics-inc-rapp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-na-names-fiserv-fisv-and-rapport-therapeutics-inc-rapp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0354030511.USD","LU2125909916.SGD","LU1201861165.SGD","LU0208291251.USD","FINX","LU1861220207.SGD","LU1046421795.USD","BK4585","BK4588","NA","BK4106","LU0320765489.SGD","LU0130102774.USD","LU0070302665.USD","FISV","BK4227","BK4007","LU2125909759.SGD","BK4141","LU1861217088.USD","LU1823568750.SGD","LU0980610538.SGD","LU1923622291.USD","RAPP","LU0130103400.USD","LU0648000940.SGD","LU1201861249.SGD","LU0354030438.USD","LU0648001328.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664142815","title":"Rapport Therapeutics to Join Cantor Global Healthcare Conference Fireside Chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2664142815","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664142815?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:02","pubTimestamp":1788346945,"startTime":"0","endTime":"0","summary":"Rapport Therapeutics to Join Cantor Global Healthcare Conference Fireside ChatRapport Therapeutics will join the Cantor Global Healthcare Conference in New York City on Sept. 9, 2026.Management will a","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDLbWhh7F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","IE00BQXX3D17.EUR","LU2210149790.SGD","IE00BQXX3C00.GBP","IE00BQXX3F31.USD","IE00BN0W2V16.EUR","BCDF","IE00BGHQF748.EUR","SG9999014021.USD","IE00BN0W2T93.GBP","NDAQ","SG9999014039.USD","RAPP","IE00BN0W2W23.USD","LU2210150020.SGD","BK4588","BK4112","LU2095319765.USD","BK4007","IE00BKPKM429.USD","LU0314104364.USD","IE00B64PRP62.GBP","SG9999014013.SGD","BK4585","SG9999014005.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664064815","title":"Rapport Therapeutics to Participate in Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2664064815","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664064815?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:00","pubTimestamp":1788346800,"startTime":"0","endTime":"0","summary":"BOSTON and SAN DIEGO, Sept.  02, 2026 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company dedicated to the discovery and ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/02/3354968/0/en/rapport-therapeutics-to-participate-in-upcoming-investor-conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RAPP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662495741","title":"Rapport Therapeutics Chief Development Officer Krishnaswamy Yeleswaram Disposes of Common Shares Worth $2.51 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662495741","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662495741?lang=en_us&edition=fundamental","pubTime":"2026-08-27 04:00","pubTimestamp":1787774433,"startTime":"0","endTime":"0","summary":"Rapport Therapeutics Chief Development Officer Krishnaswamy Yeleswaram disposes of common shares worth $2.51 millionRapport Therapeutics Chief Development Officer Yeleswaram Krishnaswamy sold 50,160 c","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDL9f4bFt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Rapport Therapeutics Chief Development Officer Krishnaswamy Yeleswaram Disposes of Common Shares Worth $2.51 Million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","RAPP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661127350","title":"Rapport Therapeutics to Host Virtual KOL Event on Bipolar Mania and RAP-219 Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2661127350","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661127350?lang=en_us&edition=fundamental","pubTime":"2026-08-24 19:02","pubTimestamp":1787569379,"startTime":"0","endTime":"0","summary":"Rapport Therapeutics to host virtual KOL event on bipolar mania and RAP-219 programRapport Therapeutics will host a virtual KOL event on Sept. 22, 2026 at 12:30 p.m. ET.Discussion will center on bipol","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nNDLsc9Xv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","LU2095319765.USD","BK4007","SG9999014039.USD","IE00B64PRP62.GBP","IE00BQXX3C00.GBP","RAPP","IE00BN0W2T93.GBP","SG9999014005.SGD","BK4588","IE00BQXX3F31.USD","IE00B3QW5Z07.USD","LU0314104364.USD","BK4112","IE00BKPKM429.USD","IE00BN0W2W23.USD","BCDF","IE00BGHQF748.EUR","SG9999014013.SGD","IE00BN0W2V16.EUR","IE00BQXX3D17.EUR","LU2210150020.SGD","SG9999014021.USD","LU2210149790.SGD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661234024","title":"Rapport Therapeutics Chief Development Officer Krishnaswamy Yeleswaram Disposes of 404 Common Shares Worth $20,159.6","url":"https://stock-news.laohu8.com/highlight/detail?id=2661234024","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661234024?lang=en_us&edition=fundamental","pubTime":"2026-08-21 04:09","pubTimestamp":1787256575,"startTime":"0","endTime":"0","summary":"Rapport Therapeutics Chief Development Officer Krishnaswamy Yeleswaram disposes of 404 common shares worth $20,159.6Rapport Therapeutics Chief Development Officer Yeleswaram Krishnaswamy sold 404 comm","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nNDL6zL9wn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Rapport Therapeutics Chief Development Officer Krishnaswamy Yeleswaram Disposes of 404 Common Shares Worth $20,159.6","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RAPP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660283706","title":"Analysts Have Conflicting Sentiments on These NA Companies: ServiceTitan, Inc. Class A (TTAN), Rapport Therapeutics, Inc. (RAPP) and Amentum Holdings, Inc. (AMTM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2660283706","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660283706?lang=en_us&edition=fundamental","pubTime":"2026-08-20 18:20","pubTimestamp":1787221209,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the NA sector with new ratings on ServiceTitan, Inc. Class A (TTAN), Rapport Therapeutics, Inc. (RAPP) and ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-na-companies-servicetitan-inc-class-a-ttan-rapport-therapeutics-inc-rapp-and-amentum-holdings-inc-amtm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-na-companies-servicetitan-inc-class-a-ttan-rapport-therapeutics-inc-rapp-and-amentum-holdings-inc-amtm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4123","AMTM","RAPP","BK4141","BK4023","TTAN","NA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660402749","title":"Analysts Offer Insights on NA Companies: Rapport Therapeutics, Inc. (RAPP) and SpaceX (SPCX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2660402749","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660402749?lang=en_us&edition=fundamental","pubTime":"2026-08-20 16:30","pubTimestamp":1787214623,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the NA sector with new ratings on Rapport Therapeutics, Inc. (RAPP) and SpaceX (SPCX). Rapport Therapeutics...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-rapport-therapeutics-inc-rapp-and-spacex-spcx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-rapport-therapeutics-inc-rapp-and-spacex-spcx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SPCH","BK4007","SPCX","SPAX","SPCU","SPCF","UFO","WSPC","ELOL","BK4141","LU2360107168.USD","MARS","LU2290526834.HKD","LOFF","BK4089","RAPP","NA","ORBX","LU1861559042.SGD","SNK","SPCM","SPCQ","LU1861220033.SGD","SSPC","WARP","LU1861558580.USD","LOFD","LU1861215975.USD","XOVR","BK4615","SPAL","SPCG","DXYZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660769334","title":"Does Widening Losses And Higher EPS Drag Change The Bull Case For Rapport Therapeutics (RAPP)?","url":"https://stock-news.laohu8.com/highlight/detail?id=2660769334","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660769334?lang=en_us&edition=fundamental","pubTime":"2026-08-20 05:31","pubTimestamp":1787175091,"startTime":"0","endTime":"0","summary":"In August 2026, Rapport Therapeutics, Inc. reported second-quarter and half-year 2026 results showing a wider net loss, with Q2 net loss at US$56.62 million and basic loss per share from continuing operations at US$1.19, both higher than the prior year period.\nThe six-month net loss rising to US$76.47 million, alongside a higher loss per share of US$1.61, highlights how spending and earnings trends are weighing more heavily on the company’s financial profile.\nWe will assess how this widening...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-rapp/rapport-therapeutics/news/does-widening-losses-and-higher-eps-drag-change-the-bull-cas","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-rapp/rapport-therapeutics/news/does-widening-losses-and-higher-eps-drag-change-the-bull-cas","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["RAPP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660442301","title":"Rapport Therapeutics Price Target Maintained with a $65.00/Share by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2660442301","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660442301?lang=en_us&edition=fundamental","pubTime":"2026-08-19 18:33","pubTimestamp":1787135580,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/RAPP/analyst-ratings","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RAPP"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":1,"totalSize":81,"code":"91000000","status":"200"}]}}